Study to Evaluate the Safety and Immunogenicity of Rabies Vaccine INDIRAB reconstituted with 1mL diluent Vs Reference Vaccine, administered Intramuscularly in healthy volunteers (Pre-Exposure).

Trial Profile

Study to Evaluate the Safety and Immunogenicity of Rabies Vaccine INDIRAB reconstituted with 1mL diluent Vs Reference Vaccine, administered Intramuscularly in healthy volunteers (Pre-Exposure).

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Aug 2016

At a glance

  • Drugs Rabies vaccine (Primary)
  • Indications Rabies
  • Focus Pharmacodynamics
  • Sponsors Bharat Biotech
  • Most Recent Events

    • 01 Aug 2010 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India record.
    • 18 Mar 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top